Back to companies
RECURSION PHARMACEUTICALS, INC.
RXRXUSNASDAQPharmaceuticals & HealthcareRECURSION PHARMACEUTICALS, INC.
Revenue
$74.7mn
YoY +26.9%
Operating income
-$648.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API